Progyny Inc’s filing revealed that its Director Payson Norman unloaded Company’s shares for reported $11258.0 on Nov 23 ’24. In the deal valued at $56.29 per share,200 shares were sold. As a result of this transaction, Payson Norman now holds 580,656 shares worth roughly $19.2 million.
Then, Livingston Mark S. sold 11,165 shares, generating $419,979 in total proceeds. Upon selling the shares at $37.62, the CHIEF FINANCIAL OFFICER now owns 50,119 shares.
Before that, Sturmer Michael E sold 6,395 shares. Progyny Inc shares valued at $240,452 were divested by the PRESIDENT at a price of $37.60 per share. As a result of the transaction, Sturmer Michael E now holds 384,553 shares, worth roughly $12.71 million.
Leerink Partners initiated its Progyny Inc [PGNY] rating to an Outperform in a research note published on February 26, 2024; the price target was $49. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. Canaccord Genuity began covering PGNY with “Buy” recommendation on September 27, 2023. BTIG Research started covering the stock on May 22, 2023. It rated PGNY as “a Buy”.
Price Performance Review of PGNY
On Monday, Progyny Inc [NASDAQ:PGNY] saw its stock jump 1.10% to $33.06. Over the last five days, the stock has lost -2.22%. Progyny Inc shares have fallen nearly -11.08% since the year began. Nevertheless, the stocks have fallen -3.45% over the past one year. While a 52-week high of $44.95 was reached on 02/16/24, a 52-week low of $29.44 was recorded on 04/18/24. SMA at 50 days reached $36.57, while 200 days put it at $36.19. A total of 0.66 million shares were traded, compared to the trading of 1.13 million shares in the previous session.
Levels Of Support And Resistance For PGNY Stock
The 24-hour chart illustrates a support level at 32.69, which if violated will result in even more drops to 32.33. On the upside, there is a resistance level at 33.39. A further resistance level may holdings at 33.73. The Relative Strength Index (RSI) on the 14-day chart is 37.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.74, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 73.25%. Stochastics %K at 15.39% indicates the stock is a buying.
The most recent change occurred on April 21, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $44 price target.
